Cardiorenal protection with dapagliflozin: An expert overview

Description

In this Product Explainer, Cardiologist Prof Andrew Sindone explains the role of dapagliflozin in cardiorenal protection in patients with heart failure, chronic kidney disease and/or type 2 diabetes. (6 mins)

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Angela Newbound

Angela Newbound

Practical Strategies to Increase Vaccination Rates This Flu Season

Prof Andrew Sindone AM

Prof Andrew Sindone AM

MRAs for Heart Failure Update - New Developments

A/Prof Ralph Audehm & Prof Simone Strasser

A/Prof Ralph Audehm & Prof Simone Strasser

Abnormal LFTs – Practical Cases Expert Q&A

Prof David Price

Prof David Price

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Andrew Sindone AM

expert

Prof Andrew Sindone AM

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital

Date published: 2 September 2025